Several carbonate derivatives of hitachimycin have been synthesized and evaluated their activities including antibacterial, cytocidal against HeLacells and in vivo antitumor against Sarcoma180. Some of these derivatives showed higher antitumor activity than hitachimycin. Amongthe derivatives, ll,15-di-O-methoxycarbonymitachimycin (2), ll,15-di-Oethoxycarbonylhitachimycin (3) and 15-0-methoxycarbonylhitachimycin (9) were most effective in in vivo assay.
moieties0. The mode of action of hitachimycin and combined effect with bleomycin has been reported by Komiyama et 
al.*>5\
Since hitachimycin is hardly soluble in water and other organic solvents, it is difficult to utilize the drug for in vivo evaluation. In the course of the chemical modification of hitachimycin to obtain highly soluble and highly active derivatives, 1 1 and 15-0-acyl derivatives have been synthesized and some of them showed superior antitumor effect in vivo, as reported in a previous paper6). In this paper, we describe the synthesis of carbonate derivatives of hitachimycin and their in vivo antitumor activities against Sarcoma 1 80.
Synthesis
Hitachimycin (1) has two hydroxy groups at the C-ll and C-15 positions in its molecule, the 1 1-hydroxy group being an enol of /3-diketone. Treatment of 1 with several alkyl chloroformate such as methyl70 , ethyl, propyl, «-butyl, iso-butyl, 2,2,2-trichloroethyl8) and vinyl chloroformate9) , in pyridine at room temperature gave the ll,15-dicarbonates (2~8), respectively. In the 13C NMRspectra of these carbonates (2~8), a paired signals assignable to carbonyl carbon of each carbonate group (3 154.9~156.2) and corresponded alkyl carbons were observed. Furthermore, up field shift (J 29.3m Hitachimycin was identified with stubomycin by their physico-chemical properties but the production strain of each compoundwas different2).
29.6) of the C-ll olefinic carbon and the C-16 carbon, and a downfleld shift of the C-15 carbon compared with that of 1 were observed, which indicated both hydroxy groups at the C-ll and C-15 positions were substituted.
In a previous report6), we showed that the hydroxy group at the C-15 position is more reactive than that at C-ll on acylation under basic conditions, but the C-ll ester bond of the diacylate is more labile than the C-15 one against hydrolysis under acidic or basic conditions. Twoalternative processes were considered for synthesis of 15-monocarbonates of hitachimycin bearing a free hydroxy group at the C-ll position. One was a selective carbonylation of the 15-hydroxy group of hitachimycin and the other a selective removal of the 1 1-carbonate group of 1 1,15-dicarbonate. When1 was treated with an equivalent amount of alkyl chloroformate in pyridine under cooling, the yield of the 15-carbonate was low and large amount of starting material was recovered. Accordingly, the solvolysis of ll,15-dicarbonate under acidic or basic condition was examined, and base solvolysis with dimethylaminewas found to be the most effective so far examined. The ll,15-dicarbonates (2-8) was treated with dimethylamine in chloroform at room temperature for 10 minutes to obtain the 15-monocarbonates (9-15) in high yields. The 13C NMR spectra of these compounds (9) (10) (11) (12) (13) (14) (15) showed signals assignable to one carbonate group and the C-ll carbon signal (8 186.2-186.6) exhibited a down field shift compared to the corresponding Hitachimycin (1) Scheme 1. because ll-Ocarbonate bondage is more labile than ll-0-acyl bondage and we could not find out a suitable blocking group for 15-hydroxy group to be removed without suffering 1 1-Ocarbonate group.
Chemical shift values for 13C NMRspectra of all synthesized carbonates are listed in Table 1 .
Cytocidal and Antibacterial Activities Cytocidal activities against HeLa cells measured by IC50 values and MIC(^g/ml) against various bacteria of hitachimycin derivatives are given in Table 2 . The 15-and 1 1,15-di-O-methoxy, ethoxy, trichloroethoxy and vinyloxycarbonyl derivatives (2, 3, 7~10, 14 and 15) showed considerable anti- 
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HeLa and antibacterial activities. Someof them, 2, 7 and 15 were comparable in cytocidal activities, and 2 and 8 were superior in antibacterial activities. There were a quantitative tendency between antibacterial activities and cytocidal activities.
Antitumor Activity Antitumor activities (increase in life span : ILS) at optimal doses of hitachimycin derivatives against Sarcoma 180 are given in Table 3 . It is notable that 1 1,15-di-Oethoxycarbonyl (3) and 15-O-methoxycarbonylhitachimycin (9) showed an increase ILS about twice, and 1 1 ,1 5-di-O-trichloroethoxycarbonyl (7) , ll,15-di-O-vinyloxycarbonyl (8), 15-0-ethoxycarbonyl (10), 15-0-trichloroethoxycarbonyl (14) and 15-0-vinyloxycarbonylhitachimycin (15) also showed considerable improvement in ILS compared with that of hitachimycin. It is interesting that length of alkyl chain affects antitumor activities and the smaller ones exhibited higher activities. In acyl derivatives, we found that ll-acylates are more effective than 15-acylates, but in this case a relationship between antitumor activity and bonding position of carbonate group was not observed. The compoundspossessed higher antitumor activity show a higher cytocidal and antibacterial activity. In spite of their higher antitumor activity in vitro and in vivo, 2, 3, 9, 10 and 14 did not show significant hemolysis activities. The solubility of these compounds in organic solvents, e.g., MeOH,EtOH, was remarkably improved. 
MICs
MICvalues against various bacteria were determined by the agar dilution method using heart infusion agar (pH 7.0).
Cytocidal Activities HeLaS3 cells were maintained in monolayers in Eagle's minimumessential mediumsupplemented with 10% bovine serum and kanamycin (100 /^g/ml) at 37°C. To determine the cytocidal activities of hitachimycin derivatives, HeLa S3 cells (5 x 104) in 1.5 ml of medium were placed in a tissue culture plate (Falcon, 24-well) and incubated for 24 hours at 37°C in a 5% CO2-95%air atmosphere. Each culture well was treated with 0.5 ml of fresh mediumcontaining a different concentration of hitachimycin, and reincubated for 72 hours. The cells were trypsinized to form a single cell suspension, and were counted in a hemocytometer.
Antitumor Activity Sarcoma 180 cells (1 x 106 cells/mouse) were inoculated ip into ICR mice on day-0. Mice received various doses (<250 mg/kg) of hitachimycin derivatives for 5 successive days from day-1. Antitumor activity was evaluated by the ILS: (T/C-l) x l00% at the optimal dose for each derivatives, where "T" is the median survival days (MSD) of the treated group and "C" is the MSDof the control group. 1 1 , 1 5-Di-O-methoxycarbonylhitachimycm (2) To a solution of 1 (320 mg) in pyridine (1.0 ml), methyl chloroformate (0.5 ml) was added and set for 4 hours at room temperature. The reaction mixture was diluted with CHC13(50 ml) and washed with H2O. The CHC13layer was dried over anhydrous sodium sulfate and evaporated under reduced pressure, to give a brown solid, which was chromatographed on a silica gel column with CHC13-MeOH 1H, ddd, /=6.6, 6.6 and 2.0Hz, 10-H), 4.20 (1H, m, 8-H), 3.38 (3H, s, 10-OCH3 
4 was prepared from 1 (300 mg) and propyl chloroformate (0.5 ml) as described in the prepara- 
5 was prepared from 1 (320 mg) and butyl chloroformate (0.5 ml) as described in the prepara- 1 1 , 1 5-Di-O-fcfl-butoxycarbonylhitachimycin (6) 6 was prepared from 1 (350jng) and iso-butyl chloroformate (0.5 ml) as described in the pre- 
